The first case of Covid-19 in Nigeria was recorded on February 27, 2020 in Lagos, and as of end-September 2021 around 205,800 confirmed cases and 2720 deaths had been recorded. The country experienced its first wave of the virus in the middle months of 2020, a larger wave at the end of 2020 and into 2021, and a third wave emerged in July 2021.
Articles & Analysis | How is Nigeria's Covid-19 vaccine rollout faring? from The Report: Nigeria 2022
Articles & Analysis | Mandatory health insurance to ease access to care in Nigeria from The Report: Nigeria 2022
While Nigeria has made notable progress on several major wellness indicators in recent years, the country is grappling with health and social consequences stemming from the Covid-19 pandemic, in addition to structural challenges related to its public health system and the rollout of universal health care (UHC). However, with Nigeria’s large and young population, and plentiful...
Articles & Analysis | Digital education to keep Nigeria’s young workforce competitive from The Report: Nigeria 2022
Securing appropriate funding for Nigeria’s education ecosystem remains one of the sector’s most important goals, and is key to improving outcomes. Underinvestment has created knock-on effects for the nation’s employment rate, with the private sector struggling to find qualified workers. More than half of all wage-paying jobs in the country are in the public sector –...
Chapter | Health and Education from The Report: Nigeria 2022
While Nigeria has made notable progress on several major wellness indicators in recent years, the country is grappling with health and social consequences stemming...
With a population of over 200m, Nigeria is a large and diversified economy, despite the government’s reliance on oil and gas revenue. While the Covid-19 pandemic and subsequent oil price crash caused a contraction in economic growth in 2020, it also led to rapid digitalisation across commerce, education and communication. This shift is expected to put Nigeria in a favourable position for recovery in the medium term.